Literature DB >> 12740911

Oligogenic segregation analysis of hereditary prostate cancer pedigrees: evidence for multiple loci affecting age at onset.

Erin M Conlon1, Ellen L Goode, Mark Gibbs, Janet L Stanford, Michael Badzioch, Marta Janer, Suzanne Kolb, Lee Hood, Elain A Ostrander, Gail P Jarvik, Ellen M Wijsman.   

Abstract

Previous studies have suggested strong evidence for a hereditary component to prostate cancer (PC) susceptibility. Here, we analyze 3,796 individuals in 263 PC families recruited as part of the ongoing Prostate Cancer Genetic Research Study (PROGRESS). We use Markov chain Monte Carlo (MCMC) oligogenic segregation analysis to estimate the number of quantitative trait loci (QTLs) and their contribution to the variance in age at onset of hereditary PC (HPC). We estimate 2 covariate effects: diagnosis of PC before and after prostate-specific antigen (PSA) test availability, and presence/absence of at least 1 blood relative with primary neuroepithelial brain cancer (BC). We find evidence that 2 to 3 QTLs contribute to the variance in age at onset of HPC. The 2 QTLs with the largest contribution to the total variance are both effectively dominant loci. We find that the covariate for diagnosis before and after PSA test availability is important. Our findings for the number of QTLs contributing to HPC and the variance contribution of these QTLs will be instructive in mapping and identifying these genes. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12740911     DOI: 10.1002/ijc.11128

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effect.

Authors:  Bao-Li Chang; Ethan M Lange; Latchezar Dimitrov; Christopher J Valis; Elizabeth M Gillanders; Leslie A Lange; Kathleen E Wiley; Sarah D Isaacs; Fredrik Wiklund; Agnes Baffoe-Bonnie; Carl D Langefeld; S Lilly Zheng; Mika P Matikainen; Tarja Ikonen; Henna Fredriksson; Teuvo Tammela; Patrick C Walsh; Joan E Bailey-Wilson; Johanna Schleutker; Henrik Gronberg; Kathleen A Cooney; William B Isaacs; Edward Suh; Jeffrey M Trent; Jianfeng Xu
Journal:  Hum Genet       Date:  2005-11-23       Impact factor: 4.132

2.  Segregation analysis of 1,546 prostate cancer families in Finland shows recessive inheritance.

Authors:  Sanna Pakkanen; Agnes B Baffoe-Bonnie; Mika P Matikainen; Pasi A Koivisto; Teuvo L J Tammela; Snehal Deshmukh; Liang Ou; Joan E Bailey-Wilson; Johanna Schleutker
Journal:  Hum Genet       Date:  2007-01-03       Impact factor: 4.132

3.  Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 Mb.

Authors:  Bo Johanneson; Shannon K McDonnell; Danielle M Karyadi; Scott J Hebbring; Liang Wang; Kerry Deutsch; Laura McIntosh; Erika M Kwon; Miia Suuriniemi; Janet L Stanford; Daniel J Schaid; Elaine A Ostrander; Stephen N Thibodeau
Journal:  Hum Genet       Date:  2007-12-08       Impact factor: 4.132

Review 4.  Prostate cancer and Hedgehog signalling pathway.

Authors:  L M Antón Aparicio; R García Campelo; J Cassinello Espinosa; M Valladares Ayerbes; M Reboredo López; S Díaz Prado; G Aparicio Gallego
Journal:  Clin Transl Oncol       Date:  2007-07       Impact factor: 3.405

5.  Prostate cancer risk-associated genetic markers and their potential clinical utility.

Authors:  Jianfeng Xu; Jielin Sun; S Lilly Zheng
Journal:  Asian J Androl       Date:  2013-04-08       Impact factor: 3.285

6.  Association of a single-nucleotide polymorphism from chromosome 17q12 with the aggressiveness of prostate cancer in a Hispanic population.

Authors:  Pablo A Rojas; Verónica Torres-Estay; Javier Cerda-Infante; Viviana P Montecinos; Javier Domínguez; José Arenas; Alejandro S Godoy; Ignacio F San Francisco
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-14       Impact factor: 4.553

7.  Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathway.

Authors:  Milton W Datta; Ana Maria Hernandez; Michael J Schlicht; Andrea J Kahler; Amy M DeGueme; Rajiv Dhir; Rajal B Shah; Cindy Farach-Carson; Andrea Barrett; Sumana Datta
Journal:  Mol Cancer       Date:  2006-03-01       Impact factor: 27.401

8.  The clinical genetics of prostate cancer.

Authors:  Sashi Kommu; Stephen Edwards; Rosalind Eeles
Journal:  Hered Cancer Clin Pract       Date:  2004-07-15       Impact factor: 2.857

9.  CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic Caucasians.

Authors:  Joke Beuten; Jonathan A L Gelfond; John J Byrne; Ivana Balic; AnaLisa C Crandall; Teresa L Johnson-Pais; Ian M Thompson; Douglas K Price; Robin J Leach
Journal:  Carcinogenesis       Date:  2008-06-09       Impact factor: 4.944

Review 10.  Dysregulation of the homeobox transcription factor gene HOXB13: role in prostate cancer.

Authors:  Brennan Decker; Elaine A Ostrander
Journal:  Pharmgenomics Pers Med       Date:  2014-08-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.